MSK Drugs Flashcards
Two main pathways for arachidonic acid metabolism
- Lipoxygenase –> Leukotrienes
2. COX pathways (COX-1, COX-2) –> Prostaglandins, Thromboxane
LBT4
Attracts neutrophils
LTC4, LTD4, LTE4
Function in bronchoconstriction, vasoconstriction, contraction of smooth muscle and increase in vascular permeability
- Target of anti-leukitriene medications in asthma
PGI2
Inhibits platelet aggregation and promotes vasodilation
PGI = “Platelet Gathering Inhibitor”
Prostaglandins (PGE2, PGF2)
- Increase uterine tone
- Decrease vascular tone
- Decrease bronchial tone
** Aspirin causes wheezing because these prostaglandins are blocked due to COX inhibiton so only bronchoconstriction causing leukotrienes are left
Thromboxane
- Increase platelet aggregation
- Increase vascular tone
- Increase bronchial tone
Aspirin: Mechanism
IRREVERSIBLY inhibits COX-1 and COX-2 by acetylation which decreases thromboxane and prostaglandins
- Increase bleeding time
- No effect on PTT, PT
Aspirin: Clinical Use
Low dose (< 300 mg/day): decreased platelet aggregation
Intermediate dose (300 - 2400 mg/day): antipyretic and analgesic
High dose (2000 - 4000 mg/day): anti-inflammatory
Aspirin: Toxicity
Gastric ulceration (due to COX-1 inhibition which maintains GI mucosa)
- Tinnitus
- Chronic use can lead to renal failure, interstitial nephritis and upper GI bleeding
- Reye’s syndrome when used in children for tx of viral infection
- Aspirin- induced asthma, Hyperventilation (respiratory alkalosis)
NSAIDS
Ibuprofen, Naproxen, Indomethacin, Ketorolac, Diclofenac
NSAIDs: Mechanism
REVERSIBLY inhibit cyclooxyenase (both COX-1 and COX-2). Block prostaglandin synthesis
NSAIDs: Clinical Use
Antipyretic, analgesic, anti-inflammatory
Tx for PDA closure
Indomethacin
NSAIDs: Toxicity
Interstitial nephritis
Gastric ulcer
Renal ischemia (PG vasodilate afferent arteriole
COX-2 inhibitors
Celecoxib